New drug combo aims to shrink tough bile duct cancers before surgery
NCT ID NCT06001658
Summary
This study is testing a combination of three drugs (gemcitabine, cisplatin, and pembrolizumab) given before and after surgery for bile duct and gallbladder cancers that can be removed by an operation. The main goals are to see if this approach is safe, if patients can still proceed to surgery on time, and if the treatment significantly shrinks the tumor before it is removed. Researchers will also closely examine the tumor tissue to understand how the immune system interacts with the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BILLIARY TRACK CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
SKCCC Johns Hopkins
RECRUITINGBaltimore, Maryland, 21231, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.